625 related articles for article (PubMed ID: 9401407)
1. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
Szczepański W
Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with chronic hepatitis B.
Koo JS; Kim H; Park BK; Ahn SH; Han KH; Chon CY; Park C; Park YN
J Clin Gastroenterol; 2008 Jul; 42(6):738-43. PubMed ID: 18277883
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants.
Le Bail B; Bernard PH; Carles J; Balabaud C; Bioulac-Sage P
J Hepatol; 1997 Nov; 27(5):835-42. PubMed ID: 9382971
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
5. Orcein staining of hepatitis B surface antigen in paraffin sections of liver on autopsy cases.
Sakurai M; Miyaji T
Acta Hepatogastroenterol (Stuttg); 1977 Oct; 24(5):334-9. PubMed ID: 73335
[TBL] [Abstract][Full Text] [Related]
6. Preneoplastic lesions in chronic hepatitis C.
Thung SN; Hytiroglou P; Fiel I; Theise N
Princess Takamatsu Symp; 1995; 25():171-8. PubMed ID: 8875622
[TBL] [Abstract][Full Text] [Related]
7. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
Mwangi J; Gatei DG
East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis.
Libbrecht L; Craninx M; Nevens F; Desmet V; Roskams T
Histopathology; 2001 Jul; 39(1):66-73. PubMed ID: 11454046
[TBL] [Abstract][Full Text] [Related]
10. [Expression of ras oncogene p21 product and proliferating cell nuclear antigen in liver cirrhosis and the correlation with liver cell dysplasia].
Feng Z; He R; Lu Z; Ling Y
Zhonghua Gan Zang Bing Za Zhi; 2000 Dec; 8(6):343-5. PubMed ID: 11135691
[TBL] [Abstract][Full Text] [Related]
11. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
12. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma. A study of 50 autopsy cases with detection of hepatitis B surface antigen in fixed tissues.
Perez-Barrios A; Colina-Ruizdelgado F; Gallego I; Martinez-Tello FJ
Pathol Res Pract; 1983 Mar; 176(2-4):131-44. PubMed ID: 6190153
[TBL] [Abstract][Full Text] [Related]
14. Nucleolar hypertrophy correlates with hepatocellular carcinoma development in cirrhosis due to HBV infection.
Trerè D; Borzio M; Morabito A; Borzio F; Roncalli M; Derenzini M
Hepatology; 2003 Jan; 37(1):72-8. PubMed ID: 12500191
[TBL] [Abstract][Full Text] [Related]
15. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis.
Lee RG; Tsamandas AC; Demetris AJ
Hepatology; 1997 Dec; 26(6):1415-22. PubMed ID: 9397980
[TBL] [Abstract][Full Text] [Related]
16. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
17. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
[TBL] [Abstract][Full Text] [Related]
18. [Primary hepatocarcinoma. Epidemiologic case-control study in the province of Bergamo].
Colloredo Mels G; Paris B; Bertone V; Angeli G
Minerva Med; 1986 Mar; 77(9-10):297-306. PubMed ID: 3005920
[TBL] [Abstract][Full Text] [Related]
19. Orcein-positive hepatitis B surface antigen and liver carcinoma: their association in an Eastern US population.
Keshgegian AA; Ochs RH
Arch Pathol Lab Med; 1981 Apr; 105(4):190-3. PubMed ID: 6163416
[TBL] [Abstract][Full Text] [Related]
20. [HBS Ag-positive hepatocellular cancer (pathomorphologic study)].
Bardadin K; Kobushevska-Farina M
Arkh Patol; 1979; 41(8):45-9. PubMed ID: 226040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
